Golgi
Curated by SignalProvider of computational platform for mass spectrometry proteomics
Overview
Provider of computational platform for mass spectrometry proteomics. It offers a solution for processing and analyzing biological information. Its tools are enabling researchers to gain deeper insights from the proteomics data. The platform leverages AI and machine learning techniques to accelerate the drug discovery process by identifying promising drug candidates, predicting drug properties, and optimizing drug molecules.
Key facts
- Founded
- 2023
- Headquarters
- San Francisco, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view